Agenus’ Botvymo and Evamplix receive marketing authorizations from Republic of Armenia for treatment of metastatic colorectal cancer: Lexington, Massachusetts Saturday, October ...
US FDA approves Roche’s Tecentriq in combo with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer: Basel Saturday, Octobe ...
NEXUS 2026 brings pharma experts together to explore next generation analytical technologies: Shardul Nautiyal, Mumbai ...
Maarga Mind Care sees mental well-being as a national development priority: Our Bureau, Bengaluru Saturday, October 10, 2026, 09:00 Hrs [IST] Maarga Mind Care views mental well-be ...
Mumbai, celebrates the outstanding achievement of Sampada Desai, final-year B.Pharm student of BNCP, who was awarded the ...
TMR on non-scheduled anti-cancer drugs may not make drugs affordable: Experts: Gireesh Babu, New Delhi Saturday, October 10, 2026, 08:00 Hrs [IST] The central government's move to ...
India is building a new quality framework for biosimilar boom: Sachin Joshi: Yash Ved, Mumbai Saturday, October 10, 2026, 08:00 Hrs [IST] The National Conference on Quality and Sa ...
Opinion
Indian needs to reduce its import dependence on pharma-adjacent chemical inputs: Raghunath Kelkar
Indian needs to reduce its import dependence on pharma-adjacent chemical inputs: Raghunath Kelkar: Nandita Vijayasimha, Bengaluru Saturday, October 10, 2026, 08:00 Hrs [IST] India ...
PCI leads nationwide anti-AMR campaign starting in Gujarat to drive public awareness: Peethaambaran Kunnathoor, Chennai Saturday, October 10, 2026, 08:00 Hrs [IST] The Pharmacy Co ...
Pharmacy colleges are increasingly adopting AI-powered education to prepare future pharmacists for a rapidly evolving healthcare landscape. The growing integration of AI is not intended to replace the ...
New UK-Singapore partnership to accelerate healthcare innovations: United Kingdom Saturday, October 10, 2026, 17:00 Hrs [IST] The NIHR and the National Health Innovation Centre Si ...
Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer: San Francisco Saturday, October 10, 2026, 15:00 Hrs [IST] Vir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results